AOSD patients | TLR7 | MyD88 | TRAF6 | IRAK4 | IRF5 | IFN-α |
---|---|---|---|---|---|---|
Activity score | 0.766*** | 0.493* | 0.481* | 0.488* | 0.151 | 0.489* |
MyD88 transcript | 0.818*** | -- | Â | Â | Â | Â |
TRAF6 transcript | 0.742*** | 0.789*** | -- | Â | Â | Â |
IRAK4 transcript | 0.701** | 0.746*** | 0.986*** | -- | Â | Â |
IRF5 transcript | 0.241 | 0.223 | 0.231 | 0.218 | -- | Â |
IFN-α transcript | 0.713** | 0.738*** | 0.988*** | 0.986*** | 0.254 | -- |
Serum IL-1β level | 0.626** | 0.424 | 0.589* | 0.531* | -0.131 | 0.556* |
Serum IL-6 level | 0.589* | 0.571* | 0.476* | 0.434 | -0.131 | 0.455 |
Serum IL-18 level | 0.732** | 0.531* | 0.451 | 0.459 | -0.033 | 0.408 |
Serum TNF-α level | 0.117 | 0.030 | 0.104 | 0.059 | -0.094 | 0.036 |
Serum IFN-α level | 0.482* | 0.517* | 0.558* | 0.589* | -0.429 | 0.571* |
SLE patients | TLR7 | MyD88 | TRAF6 | IRAK4 | IRF5 | IFN-α |
SLEDAI score | 0.782** | 0.731* | 0.486 | 0.517 | 0.355 | 0.698* |
MyD88 transcript | 0.806** | -- | Â | Â | Â | Â |
TRAF6 transcript | 0.564 | 0.842*** | -- | Â | Â | Â |
IRAK4 transcript | 0.515 | 0.685* | 0.939*** | -- | Â | Â |
IRF5 transcript | 0.115 | -0.236 | -0.152 | 0.127 | -- | Â |
IFN-α transcript | 0.661* | 0.855*** | 0.976*** | 0.952*** | -0.139 | -- |
Serum IL-1β level | 0.661* | 0.334 | 0.298 | 0.225 | -0.103 | 0.274 |
Serum IL-6 level | 0.624 | 0.134 | 0.036 | 0.012 | -0.024 | 0.036 |
Serum IL-18 level | 0.770** | 0.770** | 0.648* | 0.588 | -0.055 | 0.721* |
Serum TNF-α level | 0.261 | 0.219 | 0.413 | 0.547 | -0.292 | 0.474 |
Serum IFN-α level | 0.212 | 0.456 | 0.359 | 0.444 | -0.395 | 0.298 |